HEMEBOUND-SCD Trademark Information

Trademark by CSL Behring LLC

Educational services in the field of health and treatment; Publication of the results of clinical trials

Providing medical and scientific research information in the field of pharmaceuticals and clinical trials

Providing medical information and treatment information in the field of health, pharmaceuticals and clinical trials

Classification Information

Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.

Primary Class: Class Details:
Class (041)
Education; providing of training; entertainment; sporting and cultural activities.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
Class (042)
Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
Class (044)
Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
General Information
Word mark: HEMEBOUND-SCD
Status/Status Date:
NEW APPLICATION FILED
10/7/2021
Serial Number: 90847579
Filing Date: 7/26/2021
Foreign Filing Deadline: Wednesday, January 26, 2022
 
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Educational services in the field of health and treatment; Publication of the results of clinical trials
Mark Description: NOT AVAILABLE
Type Of Mark: Service Mark
Published For Opposition Date: N/A
Last Applicant/Owner:
CSL Behring LLC
King of Prussia, PA 19406
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
SMITH, GAMBRELL & RUSSELL, LLP
1055 THOMAS JEFFERSON STREET, NW
SUITE 400
WASHINGTON, DC 20007
Current Status:
NEW APPLICATION FILED
10/7/2021
Correspondent Search:
SCOTT D. WOLDOW is a correspondent of HEMEBOUND-SCD trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on